<http://schema.org/description>
"A follow on indication for RAVICTI will be a key area to watch for Hyperion shareholders."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/02/04/hyperion-surges-on-fda-approval-but-whats-next.aspx>